Lv1
72 积分 2023-04-04 加入
Co-infusion of CD19-targeting and BCMA-targeting CAR-T cells for treatment-refractory systemic lupus erythematosus: a phase 1 trial
1个月前
已完结
Co-infusion of CD19-targeting and BCMA-targeting CAR-T cells for treatment-refractory systemic lupus erythematosus: a phase 1 trial
1个月前
已完结
BCMA T-Cell Engager Therapy in Patients with Refractory Autoimmune Disease
1个月前
已完结
Targeted Lipid Nanoparticle Delivery of FAP-CAR mRNA Enables Potent In Vivo T-Cell Engineering Against Pancreatic Tumors
1个月前
已完结
In vivo chimeric antigen receptor (CAR)-T cell therapy
2个月前
已完结
In vivo CAR-T cell engineering in refractory SLE
3个月前
已完结
CAR T-cell therapy in SLE: A systematic review
3个月前
已完结
Efficacy and safety of allogeneic CD19 CAR NK-cell therapy in systemic lupus erythematosus: a case series in China
3个月前
已完结
Antigen experience history directs distinct functional states of CD8+ CAR T cells during the antileukemia response
3个月前
已完结
In vivo CAR engineering for immunotherapy
4个月前
已完结
皖公网安备34019202002308
